Location History:
- van Houtenlaan, NL (2002)
- Weesp, NL (2001 - 2016)
Company Filing History:
3 out of 169 
2 out of 6 
1 out of 67 
Years Active: 2001-2016
Title: Innovations of Eric Ronken
Introduction
Eric Ronken is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target S1P receptors. With a total of 6 patents to his name, Ronken's work is recognized for its potential in treating various diseases.
Latest Patents
Ronken's latest patents focus on (thio)morpholine derivatives as S1P modulators. The present disclosure relates to these derivatives, which are defined by a specific formula or a pharmaceutically acceptable salt, solvate, or hydrate thereof. Importantly, the derivatives of formula (I) are not 2-(4-ethylphenyl)-4-morpholinoethanol or 4-[4-(2-hydroxyethyl)-2-morpholinyl]benzeneacetonitrile, nor their pharmaceutically acceptable salts, solvates, or hydrates. The compounds developed by Ronken exhibit affinity to S1P receptors and may be utilized in the treatment, alleviation, or prevention of S1P receptor-mediated diseases and conditions.
Career Highlights
Throughout his career, Eric Ronken has worked with prominent companies in the pharmaceutical industry. Notable among these are Duphar International Research B.V. and AbbVie Bahamas Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Ronken has collaborated with several professionals in his field, including Jacobus A J Den Hartog and Gerben M Visser. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.
Conclusion
Eric Ronken's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work on S1P modulators demonstrates the potential for innovative treatments in medicine.